Forskolin is one such molecule, capable of directly stimulating adenylate cyclase, thereby increasing intracellular cAMP levels which are pivotal in the activation of protein kinase A (PKA) and subsequent phosphorylation of target proteins. Phorbol esters, like PMA, are known to activate PKC, a family of enzymes that play a key role in controlling the function of other proteins through phosphorylation, affecting a wide range of cellular processes. Calcium plays a vital role in cellular signaling, and chemicals like Ionomycin and A23187 serve as ionophores that elevate intracellular calcium levels. This elevation can activate a host of calcium-dependent proteins, altering their activity and effect on cellular function. Insulin engages its receptor to initiate a signaling cascade that can result in the activation of multiple proteins through the PI3K/Akt pathway, impacting processes such as glucose uptake and metabolism.
Inhibitors like U0126, SB 203580, LY294002, and Rapamycin, although they primarily act to suppress the activity of their target enzymes, can also indirectly modulate protein activity. They do so by either preventing deactivation of their targets or altering the regulation of downstream effectors, which can lead to changes in cellular dynamics and the activation status of proteins within these pathways. BML-275 and SP600125, by inhibiting BMP signaling and JNK respectively, demonstrate how the inhibition of one pathway can lead to the compensatory activation of others, influencing overall protein activity. Wnt-3a represents a chemical activator that stimulates the Wnt pathway, a critical regulator of cell fate and patterning during development, and can modulate the stability and activity of a range of proteins involved in this signaling cascade.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which is involved in regulating the function of proteins through phosphorylation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, can activate calcium-dependent proteins. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Engages the insulin receptor, initiating a cascade that can activate proteins through the PI3K/Akt pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK, indirectly increasing the activation of proteins by preventing their deactivation through phosphorylation by MEK. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, which can alter the activation state of proteins regulated by this kinase. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, which can result in the modulation of downstream protein activities within the PI3K/Akt pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds to mTOR and inhibits its activity, can lead to the differential regulation of proteins involved in cell growth and proliferation. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Inhibits BMP signaling by targeting the kinases ALK2, ALK3, and ALK6, which can influence protein activity in this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which can affect the activity of proteins that are substrates of this kinase. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore, can increase intracellular calcium levels and thus modulate the activity of calcium-binding proteins. | ||||||